OSE Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - OSE Immunotherapeutics SA

Watchlist Manager

Watchlist

Price: 3.2 EUR 0.5% Market Closed

Market Cap: €72.6m

	OSE Immunotherapeutics SA PAR:OSE	FR
C	China Life Insurance Co Ltd XMUN:CHL	CN
B	BEC World PCL SET:BEC	TH
P	PLDT Inc OTC:PHTCF	PH
J	Jardine Cycle & Carriage Ltd XMUN:CYC	SG
K	Kangda International Environmental Company Ltd F:27K	CN
	Terna Rete Elettrica Nazionale SpA MIL:TRN	IT
K	Kandenko Co Ltd F:5EY	JP

Profitability Summary

OSE Immunotherapeutics SA's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-1 592%

Negative 3Y Average Operating Margin

-667%

Declining Operating Margin

-811% > -1 592%

Negative Net Margin

-1 570%

Negative 3Y Average Net Margin

-654%

Declining Net Margin

-769% > -1 570%

Negative Free Cash Flow Margin

-1 679%

Negative 3Y Average Free Cash Flow Margin

-647%

Declining Free Cash Flow Margin

-784% > -1 679%

Negative ROE

-53%

Negative 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.